This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Looking for maximum cashback on groceries? Check out our top credit card recommendations that offer the best rewards.
24,442 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Nebius stock has drawn attention with recent deals and rising prices. This guide explores whether could buying Nebius...
March brought a mix of regulatory headlines and upbeat AI-related gains. This article breaks down what happened in th...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
The latest weekly data show the number people getting unemployment dropping to a 2½-year low, as initial claims ease ...
The Goldman Sachs retirement survey shows a split: many workers feel they’re on track for retirement goals, but a maj...
A fresh study links childhood money beliefs to adult investing behavior, prompting a shift toward mindset-first finan...
Rumble faces a pivotal quarter as it navigates growth, monetization, and cost control. This article breaks down what ...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Charis Moreno argues that success in a volatile housing market hinges on prioritizing buyers, sellers, and communitie...
A leading AI software name slammed in a broad market rotation now sits well off its highs. This guide breaks down whe...
Starting a portfolio in AI is daunting but doable. This guide lays out practical trades you could make today, with co...